Appointment of Vice President of Investor Relations

Appointment of Vice President of Investor Relations

Trading update for the period ended 31 December 2021

Abcam to acquire BioVision for $340 million

Abcam – Half Year Trading Update

Abcam Announces Pricing of Offering on NASDAQ

Abcam announces Full Year results